NCT01424423View on ClinicalTrials.gov

NOGO-A in Multiple Sclerosis FTIH

PHASE1TerminatedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

February 11, 2010

Primary Completion Date

August 26, 2010

Study Completion Date

August 26, 2010

Conditions

Multiple Sclerosis

Interventions

DRUG

Placebo

Placebo

DRUG

GSK1223249

I.V. Infusion

Trial Locations (1)

VIC 3084

GSK Investigational Site, Heidelberg

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01424423 - NOGO-A in Multiple Sclerosis FTIH | Biotech Hunter | Biotech Hunter